By Aliaksei Pustavoitau et al, Johns Hopkins University School of Medicine, USA. Although the overall mortality in the first year after liver transplantation is decreasing each year, centres… read more.
Professor Arthur Matas, University of Minnesota, Minneapolis, USA speaking at the World Transplant Congress 2014 in San Francisco.
By Allan M Concejero et al, Kaohsiung Chang Gung Memorial Hospital, Taiwan. Increased use of living donors for liver transplantations has meant an increase in donor complications and… read more.
By Vincent H Karam et al, Hôpital Paul Brousse, Villejuif, France. Liver transplantation is associated with consistent improvements in quality of life in the first three years after… read more.
World Congress on Gastrointestinal Cancer (WCGC) meeting, Barcelona 25 – 28 June 2014.
What we are doing now, what the future Holds, and how Tumour profiling is just the beginning by Dr Paul Ross, Guy’s & St Thomas’ Hospitals, London. At… read more.
by Bruce Sylvester – Ibrutinib has significantly outperformed ofatumumab as a second-line therapy for chronic lymphocytic leukemia (CLL), according to a Phase 3 study published on May 31,… read more.
by Bruce Sylvester: Fenofibrate treatment reduces cardiovascular disease risks in persons with type-2 diabetes, especially women, researchers reported on August 18 in Diabetologia.
by Bruce Sylvester: Estrogen blocking letrozole treatment results in higher birth rates in women with polycystic ovary syndrome (PCOS) than standard-therapy clomiphane, researchers reported on July 9, 2014… read more.
by Bruce Sylvester: Rapamycin appears to shrink one type of pancreatic cancer tumor and prevents it from spreading, researchers reported on August 3, 2014 in the journal Gut.
Dr. Dermot Nolan, GP at Tramore Medical Clinic, Ireland.
by Bruce Sylvester: In spite of preclinical signs of preventing tumor progression and improving survival, everolimus does not improve overall survival in patients with advanced liver cancer when… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
